Prague
,
Czech Republic
20 - 23 May 2023
Heart Failure Association of the ESC (ESC-HF 2023)
Presentation schedule and materials
The congress symposium is no longer available
Sunday, 21 May 2023
ORAL PRESENTATION
Design and baseline characteristics of the STEP-HFpEF trial programme evaluating semaglutide 2.4 mg in people with the obesity phenotype of heart failure with preserved ejection fraction
Mikhail N. Kosiborod1; Steen Abildstrøm2; Barry Borlaug3; Javed Butler4; Louise Christensen2; Melanie Davies5; G. Kees Hovingh2; Dalane Kitzman6; Marie L. Lindegaard2; Daniél Vega Møller2; Sanjiv J. Shah7; Marianne Bach Treppendahl2; Subodh Verma8; Mark C. Petrie9
Keywords